A
Andrew Stolz
Researcher at University of Southern California
Publications - 86
Citations - 4561
Andrew Stolz is an academic researcher from University of Southern California. The author has contributed to research in topics: Liver injury & Internal medicine. The author has an hindex of 36, co-authored 76 publications receiving 3805 citations. Previous affiliations of Andrew Stolz include United States Department of Veterans Affairs & University of California, Los Angeles.
Papers
More filters
Journal ArticleDOI
Features and outcomes of 899 patients with drug-induced liver injury: The DILIN prospective study
Naga Chalasani,Herbert L. Bonkovsky,Robert J. Fontana,William M. Lee,Andrew Stolz,Jayant A. Talwalkar,K. Rajendar Reddy,Paul B. Watkins,Victor J. Navarro,Huiman X. Barnhart,Jiezhun Gu,Jose Serrano,Jawad Ahmad,Nancy Bach,Meena B. Bansal,Huiman X. Barnhart,Kimberly L. Beavers,Herbert L. Bonkovsky,Francisco O. Calvo,Charissa Y. Chang,Hari S. Conjeevaram,Gregory E. Conner,Jama M. Darling,Ynto S. de Boer,Douglas T. Dieterich,Frank DiPaola,Francisco A. Durazo,James E. Everhart,Robert J. Fontana,Marwan Ghabril,David Goldstein,Vani Gopalreddy,Priya Grewal,Paul H. Hayashi,Jay H. Hoofnagle,Neil Kaplowitz,Suthat Liangpunsakul,Steven N. Lichtman,Lawrence Liu,Victor Navarro,Joseph A. Odin,Simona Rossi,Mark W. Russo,Thomas D. Schiano,Averell H. Sherker,Raj Vuppalanchi,Paul B. Watkins,Steven Zacks,Amanda Balasco,Kristin Chesney,Audrey Corne,Sherrie Cummings,Gale Groseclose,Alex Hammett,Judy Hooker,Varun Kesar,Sophana Mao,Kenari Marks,Regina McFadden,Yolanda Melgoza,Sherif Mikhail,Susan Milstein,Wendy Morlan,Val Peacock,Nidia Rosado,Tracy Russell,Maricruz Vega,Manisha Verma,Patricia F. Walker,Rachana Yalamanchili,Michelle McClanahan-Crowder,Katherine Galan,Tuan Chau,Kowsalya Ragavan,Hoss Rostami,Carmel Puglisi-Scharenbroich,Rebecca Torrance,Rebekah Van Raaphorst +77 more
TL;DR: In this article, the authors present characteristics and subgroup analyses from the first 1257 patients enrolled in the study, and conclude that there are no differences in outcomes of patients with short vs long latency of DILI.
Journal ArticleDOI
Liver Injury From Herbals and Dietary Supplements in the U.S. Drug-Induced Liver Injury Network
Victor J. Navarro,Huiman X. Barnhart,Herbert L. Bonkovsky,Timothy Davern,Robert J. Fontana,Lafaine Grant,K. Rajender Reddy,Leonard B. Seeff,Jose Serrano,Averell H. Sherker,Andrew Stolz,Jayant A. Talwalkar,Maricruz Vega,Raj Vuppalanchi +13 more
TL;DR: Liver injury from nonbodybuilding H DS is more severe than from bodybuilding HDS or medications, as evidenced by differences in unfavorable outcomes (death and transplantation).
Journal ArticleDOI
Hepatic histological findings in suspected drug-induced liver injury: systematic evaluation and clinical associations.
David E. Kleiner,Naga Chalasani,William M. Lee,Robert J. Fontana,Herbert L. Bonkovsky,Paul B. Watkins,Paul H. Hayashi,Timothy J. Davern,Victor Navarro,Rajender Reddy,Jayant A. Talwalkar,Andrew Stolz,Jiezhun Gu,Huiman X. Barnhart,Jay H. Hoofnagle +14 more
TL;DR: An approach for evaluating liver histology in DILI is described and numerous associations between pathological findings and clinical presentations are demonstrated that may serve as a foundation for future studies correlating D ILI pathology with its causality and outcome.
Journal ArticleDOI
Drug-Induced Hepatotoxicity
TL;DR: Drug-induced injury to the liver can mimic any form of acute or chronic liver disease and agents such as estrogens, chlorpromazine, and monohydroxy bile acids alter the chemical and physical properties of membranes, leading to impaired activity of carriers and pumps for bile acid and electrolytes.
Journal ArticleDOI
Idiosyncratic Drug-Induced Liver Injury Is Associated With Substantial Morbidity and Mortality Within 6 Months From Onset
Robert J. Fontana,Paul H. Hayashi,Jiezhun Gu,K. Rajender Reddy,Huiman X. Barnhart,Paul B. Watkins,Jose Serrano,William M. Lee,Naga Chalasani,Andrew Stolz,Timothy Davern,Jayant A. Talwakar +11 more
TL;DR: The profile of liver injury at presentation, initial severity, patient's race, and medical comorbidities are important determinants of the likelihood of death/transplantation or persistent liver injury within 6 months of DILI onset.